Amgen Inc. (AMGN) Presents at Piper Sandler Virtual Novel Targets in Immunology Symposium TranscriptSeeking Alpha • 02/13/26
Churchill Capital Corp XI Announces the Separate Trading of its Class A Ordinary Shares and Warrants, Commencing February 9, 2026GlobeNewsWire • 02/05/26
AMGN's Q4 Earnings & Sales Beat Estimates, Obesity Candidate in FocusZacks Investment Research • 02/04/26
Amgen: Strong Mitigation Of LOE Impact, Regulatory Tensions On Tavneos EmergeSeeking Alpha • 02/04/26
Amgen Eyes Buy Zone After Fourth-Quarter Beat As Obesity Studies MountInvestors Business Daily • 02/03/26
Kyowa Kirin Regains Global Rights To Atopic Dermatitis Drug After Amgen Collaboration EndsBenzinga • 01/30/26
Dow Jones Leader Amgen Leads These Biotech Stocks Heading Into Q4 Earnings SeasonInvestors Business Daily • 01/30/26
Countdown to Amgen (AMGN) Q4 Earnings: Wall Street Forecasts for Key MetricsZacks Investment Research • 01/29/26